Amgen will now move ahead with a phase 2 programme for AMG 133, as it tries to enter a weight-loss category that has been transformed by the approval of Novo Nordisk’s once-weekly GLP-1 agonist ...

While its adjusted earnings surged 133.3% year over year to $0.32 per share ... More news from Barchart Is Amgen Stock a Buy, Sell, or Hold as Weight-Loss Drug Trials Kick Off?

Amgen today is the biggest biotechnology company in the world, but its plush headquarters, global reach and tens of thousands of employees belie its humble origins. Founded in 1980 as Applied ...

After hours: March 18 at 7:51:02 PM EDT Loading Chart for AMGN ...

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Xtrackers S&P 500 Swap UCITS ETF - 1C USD ACC 23% SPDR S&P 500 UCITS ETF - USD DIS 23% ...

After hours: 17 March at 7:29:02 pm GMT-4 Loading Chart for AMGN ...

Pre-Market: 6:41:09 a.m. EDT Loading Chart for AMGN ...

After hours: 14 March at 19:57:35 GMT-4 Loading Chart for AMGN ...